Fairvalue-Calculator Fairvalue-Calculator
EN DE

Genesem Inc (217190) Fair Value & Analysis

Technology · KR · Market cap 75.9B KRW

Price5,150 KRW
Fair Value995.19 KRW
Upside-80.7%
Quality95/100
Evidence: Medium Range 746.39 KRW – 1,244 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Genesem Inc (217190) currently trades at 5,150 KRW, while our model-based Fair Value estimate is 995.19 KRW — implying the stock looks roughly 80.7% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Genesem Inc. develops, manufactures, and supplies automated equipment for the semiconductor back-end process in South Korea and internationally. It offers saw singulation, EMI shield equipment, laser marking/cutting, pick and place products, test handlers, flip chip smart factory equipment, wafer level PKG equipment, trim/form/singulation solutions, and PCB substrate equipment. The company was founded in 2000 and is headquartered in Incheon, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Genesem Inc (217190) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 995.19 KRW versus a price of 5,150 KRW — about −81% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 217190?
Our 21-model fair value for Genesem Inc is 995.19 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 5,150 KRW.
What is the quality score of 217190?
Genesem Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.